X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabinoid-1 receptor blocker (240) 240
humans (184) 184
overweight patients (134) 134
obesity (113) 113
rimonabant (110) 110
risk-factors (91) 91
obesity - drug therapy (78) 78
endocrinology & metabolism (65) 65
metabolic syndrome (60) 60
anti-obesity agents - therapeutic use (57) 57
risk factors (57) 57
animals (55) 55
cardiovascular risk-factors (54) 54
weight-loss (52) 52
male (49) 49
medicine, general & internal (46) 46
pharmacology & pharmacy (46) 46
piperidines - therapeutic use (46) 46
pyrazoles - therapeutic use (46) 46
female (43) 43
weight (41) 41
insulin-resistance (39) 39
obesity - complications (39) 39
randomized controlled-trial (35) 35
anti-obesity agents - adverse effects (34) 34
cardiometabolic risk-factors (33) 33
endocannabinoid system (33) 33
receptor, cannabinoid, cb1 - antagonists & inhibitors (33) 33
coronary-heart-disease (31) 31
double-blind (31) 31
orlistat (31) 31
piperidines - adverse effects (31) 31
pyrazoles - adverse effects (31) 31
treatment outcome (31) 31
weight loss (31) 31
middle aged (30) 30
pyrazoles - pharmacology (30) 30
sibutramine (30) 30
piperidines - pharmacology (29) 29
placebo-controlled trial (29) 29
diabetes (28) 28
drug therapy (28) 28
adult (26) 26
endocannabinoids (26) 26
type 2 diabetes (24) 24
cardiovascular-disease (23) 23
food-intake (23) 23
insulin resistance (23) 23
weight loss - drug effects (23) 23
nutrition & dietetics (22) 22
research (22) 22
adipose-tissue (21) 21
cannabinoid receptor antagonists (21) 21
cardiovascular diseases - prevention & control (21) 21
type-2 diabetes-mellitus (21) 21
internal medicine (20) 20
obesity - metabolism (20) 20
obesity - physiopathology (20) 20
life style (19) 19
peripheral vascular disease (19) 19
body mass index (18) 18
obese-patients (18) 18
health aspects (17) 17
aged (16) 16
bariatric surgery (16) 16
cardiac & cardiovascular systems (16) 16
cyclobutanes - therapeutic use (16) 16
exercise (16) 16
hypoglycemic agents - therapeutic use (16) 16
lipids (16) 16
obesity - therapy (16) 16
body-weight (15) 15
cannabinoid receptor modulators - metabolism (15) 15
care and treatment (15) 15
diet (15) 15
double-blind method (15) 15
mice (15) 15
prevention (15) 15
abridged index medicus (14) 14
anti-obesity agents - pharmacology (14) 14
appetite depressants - therapeutic use (14) 14
blood-pressure (14) 14
lactones - therapeutic use (14) 14
overweight (14) 14
quality-of-life (14) 14
randomized controlled trials as topic (14) 14
rats (14) 14
weight-reduction (14) 14
cardiovascular diseases (13) 13
cardiovascular diseases - etiology (13) 13
cardiovascular risk (13) 13
diabetes mellitus, type 2 - complications (13) 13
diabetes mellitus, type 2 - drug therapy (13) 13
gastroenterology & hepatology (13) 13
glucagon-like peptide-1 (13) 13
hypertension (13) 13
life-style intervention (13) 13
neurosciences (13) 13
weight control (13) 13
abdominal obesity (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Disease models & mechanisms, ISSN 1754-8411, 2012, Volume 5, Issue 5, pp. 621 - 626
The ideal anti-obesity drug would produce sustained weight loss with minimal side effects. The mechanisms that regulate energy balance have substantial... 
PHARMACOLOGICAL-TREATMENT | BODY-WEIGHT | CANNABINOID-1 RECEPTOR BLOCKER | RISK-FACTORS | ENHANCED WEIGHT-LOSS | OBESE-PATIENTS | FOOD-INTAKE | OVERWEIGHT PATIENTS | PATHOLOGY | SIBUTRAMINE | CB1 RECEPTOR | CELL BIOLOGY | Obesity - drug therapy | Drug Therapy, Combination | Humans | Anti-Obesity Agents - therapeutic use
Journal Article
Diabetes, ISSN 0012-1797, 04/2010, Volume 59, Issue 4, pp. 926 - 934
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9740, pp. 517 - 523
Journal Article